Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial
- Padmanee Sharma
- Michael Krainer
- Fred Saad
- Daniel Castellano
- Jens Bedke
- Mariusz Kwiatkowski
- Akash Patnaik
- Giuseppe Procopio
- Paweł Wiechno
- Samith Kochuparambil
- Christian Thomas
- José Ángel Arranz Arija
- Steven L. McCune
- Steinbjørn Hansen
- Gedske Daugaard
- Juan Ignacio Delgado Mingorance
- Craig Kukard
- Sumit K. Subudhi
- Sreyashi Basu
- Sonali Jindal
- Bilal A. Siddiqui
- Ana Lako
- Saurabh Gupta
- Viktor Fedorov
- Neha P. Amin
- Arancha Campos
- Yumeng Wang
- Justin M. David
- Russell K. Pachynski
2026-05-08